.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Chubb
Daiichi Sankyo
AstraZeneca
Cipla
McKesson
US Army
Merck
Harvard Business School
Accenture

Generated: December 18, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; losartan potassium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; losartan potassium and what is the scope of hydrochlorothiazide; losartan potassium freedom to operate?

Hydrochlorothiazide; losartan potassium
is the generic ingredient in two branded drugs marketed by Merck Sharp Dohme, Alembic Pharms Ltd, Apotex, Aurobindo Pharma, Cadista Pharms, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan, Prinston Inc, Sandoz, Teva Pharms, Torrent Pharms, Unichem Labs Ltd, Watson Labs, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; losartan potassium. Forty-five suppliers are listed for this compound.

Summary for hydrochlorothiazide; losartan potassium

Pharmacology for hydrochlorothiazide; losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem Labs LtdLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL204832-002Jul 21, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva PharmsLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL077157-003Apr 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Ipca Labs LtdLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL201682-003Mar 1, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin LtdLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL078245-002May 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL077732-002Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston IncLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL204901-003Nov 6, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo PharmaLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL091629-001Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL078385-001Oct 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva PharmsLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL077157-001Apr 6, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Unichem Labs LtdLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; losartan potassiumTABLET;ORAL204832-003Jul 21, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-002Nov 10, 1998► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-003Oct 20, 2005► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-002Nov 10, 1998► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-001Apr 28, 1995► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-002Nov 10, 1998► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-003Oct 20, 2005► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-001Apr 28, 1995► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-001Apr 28, 1995► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-001Apr 28, 1995► Subscribe► Subscribe
Merck Sharp DohmeHYZAARhydrochlorothiazide; losartan potassiumTABLET;ORAL020387-002Nov 10, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Accenture
UBS
Healthtrust
QuintilesIMS
Chubb
Express Scripts
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot